Discontinued — last reported Q2 '23

Investing

Acquisitions

Over 3 years (FY 2021 to FY 2024), Acquisitions shows a downward trend with a -100.0% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2016
Last reportedQ2 2023

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$116.50M$116.50M$116.50M$55.75M$55.75M$55.75M$55.75M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.68B
QoQ Change+0.0%+0.0%-52.1%+0.0%+0.0%+0.0%-100.0%
YoY Change-52.1%-52.1%-52.1%-100.0%-100.0%-100.0%-100.0%
Range$0.00$1.68B
CAGR+94.9%
Avg YoY Growth-79.5%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Huntington Bancshares's acquisitions?
Huntington Bancshares (HBAN) reported acquisitions of $1.68B in Q1 2026.
What is the long-term trend for Huntington Bancshares's acquisitions?
Over 3 years (2021 to 2024), Huntington Bancshares's acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $466.00M to $0.00.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.